eur op eanexhibitionofcreati vityandinnovation - Europe Direct Iasi
eur op eanexhibitionofcreati vityandinnovation - Europe Direct Iasi
eur op eanexhibitionofcreati vityandinnovation - Europe Direct Iasi
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
EUROINVENT 2013<br />
Class no.<br />
general condition of the child's life by co-administration of two<br />
drugs: "Pacovirina" and "Capsicozida".<br />
Advantages: Consist in obtaining a method of treatment of<br />
chronic viral hepatitis C based on the synergism of two drugs:<br />
"Pacovirina" and "Capsicozida" that can be applied even if<br />
there is a high cytolysis and in children who have<br />
contraindications to the administration of antiviral therapy.<br />
4. Medicine - Health Care - Cosmetics<br />
8.57.<br />
Title<br />
Authors<br />
Institution<br />
Patent no. MD 4177<br />
Description EN<br />
Class no.<br />
METHOD OF VACCINATION AGAINST VIRAL<br />
HEPATITIS B IN IMMUNOCOMPROMISED<br />
PERSONS<br />
IG. SPÎNU, C.SPÎNU, O SAJEN, M.ISAC, V.GURIEV,<br />
P. CHINTEA, V PÂNTEA<br />
National Center for Public Health<br />
Republic of Moldova<br />
Aim: Enhancing the effectiveness of immunization against<br />
HBV in pe<strong>op</strong>le with compromised immune status especially in<br />
pregnant women and pe<strong>op</strong>le from group with high risk of HBV<br />
infection and the reduction of the number non-responders to<br />
the vaccine by co-administration of vaccine against HBV and<br />
an vegetable adaptogen - Mestim, which manifests mainly<br />
stimulating immunogenesis process.<br />
Solution: Intensification of immunogenesis expressed by a<br />
significant titers of protective antibody, resulting in<br />
minimizing the risk of HBV cases in pe<strong>op</strong>le with compromised<br />
immune status including pregnant women and the reduction of<br />
the number of non-responders to the vaccine.<br />
Advantages: Mestim is of plant origin free of cumulative,<br />
toxic, action, teratogenic, rezorptive, carcinogenic action,<br />
medicinal product do not devel<strong>op</strong> side effects and is easily<br />
tolerated by patients.<br />
4. Medicine - Health Care - Cosmetics<br />
8.58.<br />
Title<br />
Authors<br />
Institution<br />
Patent no.<br />
METHOD OF CHILDREN REVACCINATION<br />
AGAINST HEPATITIS B<br />
O. SAJEN, V.GURIEV, C. SPÎNU, I. SPÎNU, V.<br />
PÂNTEA<br />
National Center for Public Health<br />
Republic of Moldova<br />
MD 223 Y<br />
INTERNATIONAL EXHIBITS<br />
104